tren and retatrutide vs Mounjaro: triple agonist versus dual agonist compared Retatrutide in a bodybuilding prep…,

Policy, Employer Perspectives and Strategies Employers offering health benefits were asked about several aspects of their plan designs, network and coverage

This study found that GLP-1 treatment had a 2.11 HR of developing wet AMD: 0.2% of GLP-1 treated patients developed wet AMD compared to 0.1% of control

White tomatoes contain almost no lycopene and beta-carotene to get their creamy, white hues

Urva, et al., LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept, 2022, Cell Metabolism 34, 12341247

New research published in JAMA Psychiatry suggests that GLP-1 use may be higher among people with eating disorders compared to the general population